Scientists from the Jules Bordet Institute and the University of Liège develop a predictive biomarker for a rare form of leukemia
New biomarker predicts the onset of aggressive leukemia years before symptoms appear
Movember 2025
6 November will be entirely dedicated to prostate cancer at the Jules Bordet Institute
Hôp’Voices: the podcast of the Brussels University Hospital
The Brussels University Hospital (H.U.B.) is launching its own podcast channel: Hôp’Voices.
Aphinity trial: New Progress in the treatment of HER2-positive breast cancer
A targeted dual therapy improves the survival of patients with HER2+ breast cancers with lymph node positivity.